Acumen Pharmaceuticals (ABOS) EBITDA (2021 - 2026)
Acumen Pharmaceuticals (ABOS) reported EBITDA of -$32.55 million for Q2 2026, compared with -$41.73 million a year earlier.
Powered by 
Analysis
Acumen Pharmaceuticals (ABOS) EBITDA (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Acumen Pharmaceuticals' EBITDA came in at -$105.37 million; for FY2025, it was -$123.77 million.
- By year, EBITDA came in at -$113.95 million in FY2024, -$61.08 million in FY2023, -$45.21 million in FY2022 and -$19.58 million in FY2021.
- Five-year quarterly EBITDA spans a low of -$41.73 million in Q2 2025 and a high of -$8.41 million in Q4 2021.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$21.14 million (Q1 2026), -$25.19 million (Q4 2025) and -$26.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.50 Bn | 1,103.09 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 500.82 Bn | 473.93 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 367.31 Bn | 321.69 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.77 Bn | 261.76 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.35 Bn | 235.04 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.59 Bn | 164.79 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 169.39 Bn | 116.04 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Acumen Pharmaceuticals | 149.92 Mn | -332.15 Mn | - | -32.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.55 Mn |
| Mar 31, 2026 | -21.14 Mn |
| Dec 31, 2025 | -25.19 Mn |
| Sep 30, 2025 | -26.50 Mn |
| Jun 30, 2025 | -41.73 Mn |
| Mar 31, 2025 | -30.36 Mn |
| Dec 31, 2024 | -39.58 Mn |
| Sep 30, 2024 | -32.25 Mn |
| Jun 30, 2024 | -24.36 Mn |
| Mar 31, 2024 | -17.76 Mn |
| Dec 31, 2023 | -18.47 Mn |
| Sep 30, 2023 | -16.03 Mn |
| Jun 30, 2023 | -13.46 Mn |
| Mar 31, 2023 | -13.12 Mn |
| Dec 31, 2022 | -14.24 Mn |
| Sep 30, 2022 | -11.36 Mn |
| Jun 30, 2022 | -10.41 Mn |
| Mar 31, 2022 | -9.20 Mn |
| Dec 31, 2021 | -8.41 Mn |
API Access
Acumen Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ABOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ABOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ABOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();